JL

Julu Lahkar

Active Director Director DIN 08086652
DIN 08086652 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Julu Lahkar

Data last updated:

Julu Lahkar is a Director at Bionuva Caresoft Drugs & Pharma Private Limited (since 2018). The company operates in Pharma. Bionuva Caresoft Drugs & Pharma Private Limited reported revenue of ₹16.4 Lakh (FY 2022).

DIN 08086652
Primary Designation Director
Industry Pharma
First Appointment 15 Mar 2018
Oldest Company Age 8 yrs
Largest company Bionuva Caresoft Drugs & Pharma Private Limited · ₹16.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20182018₹16.4 Lakh (FY 2022)Active

Board colleagues of Julu Lahkar

Directorship timeline

Open interactive timeline →
Bionuva Caresoft Drugs & Pharma Private Limited
Premium access

Shareholding and investment profile for Julu Lahkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Julu Lahkar

Julu Lahkar currently holds 1 directorship: Bionuva Caresoft Drugs & Pharma Private Limited (Director, since 15 Mar 2018, revenue ₹16.4 Lakh (FY 2022)).

Julu Lahkar was first appointed on 15 Mar 2018 as Director at Bionuva Caresoft Drugs & Pharma Private Limited.

The current boards of Julu Lahkar's companies include Dipi Lahkar (Bionuva Caresoft Drugs & Pharma Private Limited), Ranjit Kaushik (Bionuva Caresoft Drugs & Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available